BridgeMD
New treatment option for Opioid Use Disorder
Official title An Intervention Mapping Approach to Closing the Gap in Maternal OUD and Infant NAS Care (SUPPORT)
ClinicalTrials.gov ID: NCT06576323
What this study is testing
- What it's testing
- The purpose of this study is to address the gap in maternal OUD treatment and infant neonatal opioid withdrawal syndrome care. The research team will develop a treatment model and a set of strategies to provide evidence-based OUD treatment to postpartum mothers in NICUs.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- for Interview Participants in Aim 1:
- Participants should be healthcare providers working within UPHS, who generally treat perinatal women or any individuals with OUD; for the purposes of...
- Participants should provide direct care to NICU patients and/or their mothers
- Participants should be proficient in English language
- Participants should have access to a computer with internet connectivity or phone for Mothers in Aim 1:
You likely can't join if
- for Interview Participants in Aim 1:
- \- None
- Exclusion Criteria for Mothers in Aim 1:
- \- None
- Exclusion Criteria for Clinicians in Aim 3:
- \- None
See the full eligibility criteria
- for Interview Participants in Aim 1:
- Participants should be healthcare providers working within UPHS, who generally treat perinatal women or any individuals with OUD; for the purposes of this study, provider refers to a Medical Doctor (MD) or Doctor of...
- Participants should provide direct care to NICU patients and/or their mothers
- Participants should be proficient in English language
- Participants should have access to a computer with internet connectivity or phone for Mothers in Aim 1:
- Participants should be biological mothers of children hospitalized in the UPHS NICU for NAS
- Participants should be diagnosed with opioid use disorder for Clinicians in Aim 3:
- See above for for interview participants.
- We will use this same criteria to recruit new participants for Aim 3 if the same stakeholder interviewees are unavailable at the time of Aim 3. for Mothers in Aim 3:
- Participants should be biological mothers of a child hospitalized in either of the two UPHS NICU for NAS (either HUP or PAH)
- Participants should be no more than 4 weeks postpartum
- Participants should have an Opioid Use Disorder than is currently untreated with medication assisted treatment or buprenorphine
- for Interview Participants in Aim 1:
- \- None
- Exclusion Criteria for Mothers in Aim 1:
- \- None
- Exclusion Criteria for Clinicians in Aim 3:
- \- None
- Exclusion Criteria for Mothers in Aim 3:
- \- Active suicidal ideation, or other severe psychopathology that must be addressed before effective MOUD can be prescribed
The study team makes the final eligibility decision.
Where it's taking place
- Philadelphia, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.